The National Organization for Medicines (EOF) announced on Tuesday the recall of several batches of the thyroid medication Inacalcet produced by Pharmazac from the Greek market due to the possible presence of toxic substances. The recall affects batches 2202370D and 2202370G for the 60 mg tablets, and batch 2202371D for the 90 mg tablets, following […]
The product does not have marketing authorization as a medicine by the Greek regulatory authorities. As a result, its safety and efficacy have not been evaluated